Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)

Gastroenterol Hepatol. 2022 Nov;45(9):724-734. doi: 10.1016/j.gastrohep.2022.02.005. Epub 2022 Mar 3.
[Article in English, Spanish]

Abstract

This is a meeting report of the 3rd Translational Hepatology Meeting held in Alicante, Spain, in October 2021. The meeting, which was organized by the Spanish Association for the Study of the Liver (AEEH), provided an update on the recent advances in the field of basic and translational hepatology, with a particular focus on the molecular and cellular mechanisms and therapeutic targets involved in metabolic-associated fatty liver disease (MAFLD), metabolic-associated steatohepatitis (MASH), cirrhosis and end-stage hepatocellular carcinoma (HCC).

Keywords: Carcinoma hepatocelular; Esteatohepatitis; Esteatosis; Fibrosis; Hepatocellular carcinoma; MAFLD; MASH; Steatohepatitis.

Publication types

  • Review

MeSH terms

  • Carcinoma, Hepatocellular* / complications
  • Carcinoma, Hepatocellular* / therapy
  • Gastroenterology*
  • Humans
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / pathology
  • Liver Neoplasms* / complications
  • Liver Neoplasms* / therapy
  • Non-alcoholic Fatty Liver Disease* / complications
  • Non-alcoholic Fatty Liver Disease* / pathology
  • Non-alcoholic Fatty Liver Disease* / therapy